cTnT介导的肌节-线粒体通讯破坏导致扩张型心肌病
本研究利用家族性扩张型心肌病(DCM)患者来源的诱导多能干细胞(iPSC)及携带cTnT(p.K185E)变异的小鼠模型,揭示该变异削弱cTnT与14-3-3蛋白结合,激活RAS/RAF1-p44/42-DRP1/MFF轴,导致线粒体过度分裂和DCM表型。抑制线粒体分裂可改善小鼠DCM表型。
要点
- cTnT(p.K185E)变异通过减弱与14-3-3蛋白结合,异常激活RAS/RAF1-p44/42信号,促进线粒体分裂。
- 在iPSC来源心肌细胞、心脏类器官及敲入小鼠中均重现肌节紊乱、线粒体碎片化和心功能障碍。
- 线粒体分裂抑制剂Mdivi-1可减轻敲入小鼠的DCM表型,提示靶向14-3-3或p44/42激酶可能成为治疗策略。
核心结论
- cTnT(p.K185E)变异破坏肌节-线粒体通讯,通过14-3-3蛋白介导的RAS/RAF1-p44/42-DRP1/MFF轴加速线粒体分裂,导致DCM。
研究设计与样本
- 研究使用DCM家族队列来源的iPSC,通过CRISPR-Cas9纠正TNNT2(c.A553G)变异,并建立携带等价p.K192E变异的敲入小鼠模型。
主要发现
- 全外显子测序鉴定出cTnT(p.K185E)为家族性DCM的致病变异。
- 患者iPSC来源心肌细胞显示肌节紊乱和线粒体碎片化伴严重线粒体功能障碍。
- cTnT(p.K185E)与14-3-3蛋白结合减弱,导致14-3-3从肌节结构解离并异常激活RAS/RAF1轴,引起DRP1和MFF磷酸化。
- 敲入小鼠重现人类DCM特征,包括心功能障碍、心室扩张、肌节紊乱和线粒体碎片化。
- Mdivi-1在体内减轻DCM表型。
关键数值与推荐
- cTnT变异为p.K185E(人类)和p.K192E(小鼠),TNNT2核酸变异为c.A553G。
临床怎么用
- 针对14-3-3蛋白和p44/42激酶活性的治疗策略可能对DCM及相关线粒体动力学异常心脏病有前景。
局限性
- 研究基于特定家族性DCM变异,结论推广至其他DCM亚型需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation between sarcomeres and mitochondria. Mitochondrial stress dysregulation is linked to DCM progression, yet mechanisms remain unclear. In this study, we investigated the effects of cTnT (cardiac troponin T) dysregulation on sarcomere-mitochondrial communication in DCM. METHODS: Induced pluripotent stem cells (iPSCs) derived from a DCM family cohort were used in this study, and CRISPR-Cas9 genome editing was used to rectify the TNNT2 (c.A553G) sequence variation in iPSCs. A knock-in mouse model harboring the (p.K192E) sequence variation, equivalent to the human cTnT (p.K185E) sequence variation, was subsequently established. The pathological phenotypes were analyzed in iPSC-derived cardiomyocytes, iPSC-derived cardiac organoids, and mice. RNA sequencing, metabolite profiling, and coimmunoprecipitation mass spectrometry were used to elucidate the molecular mechanisms. RESULTS: Through whole exome sequencing, we identified a novel pathogenic variant in cTnT (p.K185E) as the causal sequence variation in a familial DCM cohort. In iPSC-derived cardiomyocytes from patients with DCM, we observed sarcomere disarray and mitochondrial fragmentation accompanied by severe mitochondrial dysfunction. The diminished interaction between cTnT (p.K185E) and 14-3-3 proteins resulted in the dissociation of 14-3-3 proteins from sarcomeric structures. The free 14-3-3 proteins aberrantly engaged in the RAS/RAF1 signaling axis, driving aberrant p44/42 kinase activation that culminated in the phosphorylation of mitochondrial fission regulators DRP1 (dynamin-related protein 1) and MFF (mitochondrial fission factor). These observations were replicated in iPSC-derived cardiac organoids. The knock-in mice bearing the orthologous cTnT sequence variation faithfully recapitulated the hallmark features of human DCM, including cardiac dysfunction, ventricular dilatation, sarcomeric disarray, and mitochondrial fragmentation. Mdivi-1, a mitochondrial fission inhibitor, alleviated DCM phenotypes in vivo. CONCLUSIONS: Our findings delineate a novel pathogenic mechanism underlying DCM, demonstrating that cTnT (p.K185E) sequence variation disrupts sarcomere-mitochondrial communication by weakening the interaction between cTnT and 14-3-3 proteins, thereby accelerating mitochondrial fragmentation through excessive activation of the 14-3-3 protein-mediated RAS/RAF1-p44/42-DRP1/MFF signaling axis. Therefore, therapeutic targeting of 14-3-3 proteins and p44/42 kinase activity may represent a promising strategy for DCM and other cardiac diseases associated with aberrant mitochondrial dynamics.
引用
- Ye L, Liu J, Lei W, et al. Disruption of cTnT-Mediated Sarcomere-Mitochondrial Communication Results in Dilated Cardiomyopathy. Circulation. 2025. PMID: 40421531. doi:10.1161/CIRCULATIONAHA.125.071523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。